Microplastics in Cosmetics: What Testing Methods Actually Detect — And Why US Brands Can't Wait Any Longer

The Microbead-Free Waters Act of 2015 was supposed to resolve the microplastics problem in personal care products. Eleven years later, more than 40 distinct synthetic polymer particle types can still legally appear in a US rinse-off cosmetic — and most brands have no analytical data to tell them whether those polymers are in their formulas or not.

That’s not a fringe concern. Peer-reviewed analyses published over the past five years have consistently found microplastic particles across a wide range of cosmetic product categories, including leave-on products like foundations, mascaras, and conditioners that have never triggered any US regulatory action. The particles range from polyethylene fragments to nylon-12 to acrylates copolymers — none of which fall within the narrow scope of the 2015 federal ban.

The testing picture is complicated. And the regulatory landscape, particularly in California and in export markets, is moving in a direction brands should not ignore.

What “Microplastics” Actually Means in a Cosmetic Formula

The microbead conversation framed microplastics narrowly: small polyethylene spheres added to scrubs and cleansers for physical exfoliation. The Microbead-Free Waters Act targeted exactly that — particles smaller than 5 millimeters, intentionally added for cleansing or exfoliation purposes, in rinse-off products only.

That definition misses most of the real exposure.

Microplastics in cosmetics also include synthetic polymer particles used as film-formers, texture modifiers, thickening agents, and coatings. Acrylates/octylacrylamide copolymer is widely used in mascara for water resistance. Nylon-12 (polyamide-12) appears in loose powder foundations as a sensory modifier. Polyethylene terephthalate gives shimmer and glitter effects in highlighters and eyeshadow. These aren’t there to exfoliate — they serve genuine functional roles — but chemically and physically, they are microplastic particles.

The EU’s European Chemicals Agency (ECHA) recognized this scope in September 2023 when it finalized a restriction under REACH (Commission Regulation (EU) 2023/2055) covering intentionally added synthetic polymer particles across a broad range of applications. The restriction targets particles with at least one dimension below 5 mm in dozens of polymer chemistries. Exemptions exist for polymers that are biodegradable, water-soluble, or structurally modified to reduce persistence — but qualifying for those exemptions requires analytical documentation, not just a supplier declaration.

In the US, there’s no comparable federal framework beyond microbeads. But California’s track record on cosmetic ingredient restrictions suggests that gap is temporary.

The Four Methods Cosmetic Testing Laboratories Actually Use

Detecting microplastics analytically is genuinely hard. Unlike a heavy metals screen by ICP-MS, where you’re measuring atomic signatures, microplastics identification requires characterizing polymer chemistry at particle sizes measured in microns. Cosmetic matrices add another layer of complexity: colorants, UV filters, emulsifiers, and fragrances all interfere with detection in ways that environmental water samples do not.

The four analytical approaches currently used by cosmetic testing laboratories are meaningfully different in what they can and can’t see:

µFTIR (Micro Fourier-Transform Infrared Spectroscopy) is the established workhorse for particles above approximately 20 µm. The technique filters particles onto a membrane, then maps each particle’s infrared absorption spectrum against a reference polymer library to identify chemistry and count particles per gram of product. It handles a wide range of polymer types well and generates size distribution data. Below 20 µm, sensitivity drops and the technique becomes unreliable.

µRaman Spectroscopy pushes detection limits down to 1–5 µm — meaningfully smaller than µFTIR — and handles dark-colored or pigmented samples better in some configurations. It’s the preferred method when you need to characterize particles in that 1–20 µm range that µFTIR misses. The tradeoff: fluorescence interference from cosmetic ingredients (particularly colorants and UV absorbers) creates significant signal-to-noise challenges. Sample preparation for cosmetic matrices often requires additional steps not needed for environmental samples.

Pyrolysis-GC/MS takes a fundamentally different approach. Rather than characterizing individual particles, it thermally degrades the sample and identifies polymer types by their characteristic pyrolysis products. It’s well-suited for the question “does this formula contain nylon-12 above a certain mass concentration?” — but it doesn’t generate particle counts or size distributions. For ingredient-level screening and regulatory documentation where mass fractions matter more than particle counts, it’s highly practical and widely available.

Thermal Desorption-GC/MS (TED-GC/MS) is newer and is gaining adoption in European environmental and cosmetic testing programs. It’s faster than pyrolysis-GC/MS for some polymer types and has been used in German regulatory laboratories for quantifying common polymers including polyethylene and polypropylene. Method validation for complex cosmetic matrices is still maturing, but the technique is worth tracking.

No single method provides complete coverage. A thorough microplastics characterization program typically pairs µFTIR or µRaman for particle identification and counting with pyrolysis-GC/MS or TED-GC/MS for mass quantification. The choice of which combination depends on the product type, the polymer types of concern, and what the data will be used for.

What the Regulatory Picture Looks Like Right Now

For US brands with no EU exposure, the federal picture is quiet. FDA has not issued guidance extending microplastics regulation beyond the 2015 microbead definition, and no microplastics-specific rulemaking is visible on the current regulatory calendar.

California is the variable. The state’s Stormwater Policy already requires microplastics monitoring in treated drinking water and inland waterways — and the environmental data generated by that monitoring is building a documented record of consumer product contributions. The California Safe Cosmetics Act, Prop 65, and the state’s history with PFAS restrictions (which predated federal action by years) all point toward eventual microplastics legislation. It’s not imminent. But brands that have characterized their formulas will be in a far better position when it arrives.

For brands with EU market exposure — or EU-based retail partners — the timeline is concrete. The REACH restriction that came into force in October 2023 sets phase-in deadlines of October 2027 for rinse-off cosmetics and October 2029 or later for leave-on products, depending on product category. Brands selling into EU retail channels need documentation confirming that polymer particles in their formula either fall outside the restriction’s scope or qualify for a specified exemption. That documentation increasingly requires third-party analytical data from a cosmetic testing laboratory — a self-declaration from the ingredient supplier is not sufficient to satisfy retailer and distributor requirements.

There’s a practical supply chain reality here even for brands with zero current EU sales. We’ve seen US cosmetic brands receive compliance questionnaires from EU-based contract manufacturers and distributors who are themselves building REACH documentation packages. The request flows upstream regardless of where the brand ultimately sells.

Building a Practical Microplastics Testing Program

The goal isn’t to test every finished product batch for microplastics on an ongoing basis — at least not yet. For most brands, the pragmatic starting point is a formula audit: identify which raw materials in your current formulas are synthetic polymer particles, cross-reference them against the REACH restriction’s polymer list and exemption criteria, and flag the ones most likely to draw regulatory attention.

From there, a tiered approach makes sense for most cosmetic brands:

Tier 1 — Ingredient-level screening. Commission pyrolysis-GC/MS analysis on individual raw materials suspected of containing microplastics. Supplier COAs almost never include microplastics characterization — this is data you need to generate yourself. Focus first on film-formers, texture modifiers, and any ingredient described as a “microsphere” or “powder” in the supplier technical sheet.

Tier 2 — Finished product characterization. For products with EU market exposure, or any formula that raised concerns during the Tier 1 audit, a full µFTIR or µRaman analysis of the finished product provides particle counts, size distribution data, and polymer type identification. This is the data that supports REACH restriction exemption documentation and retailer compliance questionnaires.

Tier 3 — Reformulation verification. If you’re substituting out a polymer particle ingredient, test the reformulated product to confirm the replacement ingredient doesn’t introduce a different regulated or soon-to-be-regulated microplastic. This step gets skipped surprisingly often.

The brands taking this seriously right now aren’t responding to an FDA warning letter. They’re applying the same logic to microplastics that they applied to PFAS in 2022 and to lead limits in color cosmetics a decade before that: foreseeable regulatory risk is cheaper to characterize early than to respond to under deadline. The analytical tools exist, the methods are validated, and the regulatory direction is clear enough.

If your formula audit hasn’t yet accounted for synthetic polymer particles, that’s the first conversation worth having with your cosmetic testing laboratory.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• EU Cosmetics Regulation and REACH Compliance for US Exporters — Specialized guidance on navigating EU 1223/2009 and REACH restrictions for brands entering European markets.
• Raw Material Supplier Qualification and COA Verification — Third-party testing and documentation support for ingredient buyers who need verified polymer identity data from their supply chain.
• FDA Regulatory Strategy and Compliance Consulting — Expert consulting for brands building compliance documentation programs ahead of anticipated FDA regulatory action.